The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma by Shi, Hong et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Cancer
Open Access Research article
The effect of proteoglycans inhibited by RNA interference on 
metastatic characters of human salivary adenoid cystic carcinoma
Hong Shi1, Jie Wang*1, Fusheng Dong2, Xu Wang1, Hexiang Li1 and 
Yali Hou1
Address: 1Department of Oral Pathology, Key Laboratory of Stomatology, College of Stomatology, Hebei Medical University, Hebei Province, No. 
383 Zhongshan East Road, Shijiazhuang, PR China and 2Department of Oral and Maxillofacial surgery, College of Stomatology, Hebei Medical 
University, Hebei Province, No. 383 Zhongshan East Road, Shijiazhuang, PR China
Email: Hong Shi - shihong_hb@163.com; Jie Wang* - wangjiephd@163.com; Fusheng Dong - dongfsh@126.com; 
Xu Wang - wangxu63@hotmail.com; Hexiang Li - Lihexiang-2008@163.com; Yali Hou - yl_hstudent@sina.com
* Corresponding author    
Abstract
Background: Salivary adenoid cystic carcinoma (SACC) is one of the most common malignancies
of salivary gland. Recurrence or/and early metastasis is its biological properties. In SACC, neoplastic
myoepithelial cells secrete proteoglycans unconventionally full of the cribriform or tubular and
glandular structures of SACC. Literatures have demonstrated that extracellular matrix provided an
essential microenvironment for the biological behavior of SACC. However, there is rare study of
the effect of proteoglycans on the potential metastasis of SACC.
In this study, human xylosyltransferase-I (XTLY-I) gene, which catalyzes the rate-limited step of
proteoglycans biosynthesis, was knocked down by RNA interference (RNAi) to inhibit the
proteoglycans biosynthesis in SACC cell line with high tendency of lung metastasis (SACC-M). The
impact of down-regulated proteoglycans on the metastasis characters of SACC-M cells was
analyzed and discussed. This research could provide a new idea for the clinical treatment of SACC.
Methods: The eukaryotic expression vector of short hairpin RNA (shRNA) targeting XTLY-I gene
was constructed and transfected into SACC-M cells. A stably transfectant cell line named SACC-
M-WJ4 was isolated. The XTLY-I expression was measured by real-time PCR and Western blot;
the reduction of proteoglycans was measured. The invasion and metastasis of SACC-M-WJ4 cells
were detected; the effect of down-regulated proteoglycans on the potential lung metastasis of nude
mice was observed, respectively.
Results: The shRNA plasmid targeting XTLY-I gene showed powerful efficiency of RNAi. The
mRNA level of target gene decreased by 86.81%, the protein level was decreased by 80.10%,
respectively. The silence of XTLY-I gene resulted in the reduction of proteoglycans significantly in
SACC-M-WJ4 cells. The inhibitory rate of proteoglycans was 58.17% (24 h), 66.06% (48 h), 57.91%
(72 h), 59.36% (96 h), and 55.65% (120 h), respectively. The reduction of proteoglycans suppressed
the adhesion, invasion and metastasis properties of SACC-M cells, and decreased the lung
metastasis of SACC-M cells markedly either.
Conclusion: The data suggested that the silence of XTLY-I gene in SACC-M cells could suppress
proteoglycans biosynthesis and secretion significantly. The reduction of proteoglycans inhibited cell
adhesion, invasion and metastasis of SACC-M cells. There is a close relationship between
proteoglycans and the biological behavior of SACC.
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Background
Proteoglycans are important macromolecules, which
show the largest and most complex molecular structures
in human body. Proteoglycans are also the major compo-
nents of the extracellular matrix and consist of core pro-
tein and glocosaminoglycans (GAGs) chains which
attached to the core protein. Proteoglycans are increas-
ingly implicated as important regulators in many biologi-
cal processes, such as extracellular matrix deposition,
cytoplasmic membrane signal transfer, cell differentia-
tion, adhesion and migration, normal and tumor cell pro-
liferation, etc [1-3]. With the development of studies in
proteoglycans, more and more researchers have paid
attention to the function of proteoglycans in tumorigene-
sis and biological behavior of tumors.
Proteoglycans mainly composed of core protein and
GAGs chains are polyanionic molecules located in the
extracellular matrix or the cell surface and serve a wide
range of functions. Proteoglycans mediate diverse cellular
processes through interaction with a variety of cytokines
and protein ligands and there are many cell factors in
themselves too. The GAGs chains attached to the core pro-
tein are involved in most of these functions by holding
different cytokines and ligands. Thus, the biological fea-
ture and function of proteoglycans are intimately related
to the biosynthesis of GAGs chains [3-5]. The sulfated
GAGs which are the major proteoglycans components,
such as chondroitin sulfate, heparan sulfate, heparin, and
dermatan sulfate, etc. are bound to the proteoglycans core
protein by a common xylose-galactose-galactose binding
region: a tetrasaccharid core (GlcAβ1-3Galβ1-3Galβ1-
4Xylβ1-O-Ser). Xylosyltransferase-I (XTLY-I) is the chain-
initiating enzyme in the biosynthesis of this tetrasaccharid
core of glycosaminoglycan-containing. This enzyme cata-
lyzes the transfer of xylose from UDP-xylose to selected
serine residues in the proteoglycans core protein, which is
the initial and rate-limited step in the proteoglycans bio-
synthesis of human. XTLY-I is a key to the biosynthesis of
this tetrasaccharid core, which is shared by most prote-
oglycans, so it has been thought that XTLY-I is a regulatory
factor in proteoglycans biosynthesis [6,7]. As XTLY-I is the
initial enzyme in the biosynthesis of the glycosaminogly-
can linkage region and secreted from the Golgi compart-
ment into the extracellular space together with
proteoglycans to a great extent, it had been determined
that the activity of XTLY-I is a crucial and diagnostic bio-
chemical marker of an altered proteoglycans biosynthesis
in human body. The effect of XTLY-I on human health
and diseases has become a new research focus in recent
two years [8-10].
Salivary adenoid cystic carcinoma (SACC) is one of most
common malignancy of salivary gland, accounting for
approximately 10% of salivary gland tumors and 30% of
human salivary gland malignancy. Recurrence or/and
early metastasis is its biological properties. SACC with
high metastasis property occurs in all ages with a peak
incidence of 40~60 years old and it is not sensitive to radi-
otherapy or chemotherapy. Clinical investigation showed
that the incidence of SACC with distant metastasis, ranged
from 35% to 50% of all cases, lung was the most common
organ of its distant metastasis [11]. Distant metastasis of
SACC cells often defeats the treatment of patients with
SACC, and it is associated with a low long-term survival
rate. Follow-up investigations have revealed that the lung
metastasis is still the leading death cause of patients with
SACC. At present, there is no any effective clinical therapy
against the invasion and metastasis of SACC [12,13].
It has been proved that SACC is composed of two kinds of
cells: neoplastic duct epithelial cells and neoplastic
myoepithelial cells, the latter are the chief proliferative
cells in SACC which could express salivary tumor markers
such as smooth muscle actin, myosin, S-100 protein and
GFAP, et al. The neoplastic myoepithelial cells secrete
abundant proteoglycans full of the cribriform or tubular
and glandular SACC [14,15]. A large number of studies
have approved the close relationship between extracellu-
lar matrix and the biological features of SACC [14-16]. It
has determined that extracellular matrix provides the
essential microenvironment for the growth and metastasis
of SACC. Being an important component of extracellular
matrix, the abnormal proteoglycans play a very complex
role in the carcinogenesis and metastasis of SACC. How-
ever, there is rare study of the relationship of proteogly-
cans and the metastasis behavior of SACC. The impact of
proteoglycans on the metastasis mechanism of SACC is
still unknown.
RNA interference (RNAi) is one of the most powerful
gene-blocking technologies so far. RNAi can silence the
expression of a special gene efficiently and rapidly by
inhibiting the transcription product and down-regulate
the protein expression of the target gene. A number of
experimental studies have made it clear that RNAi could
suppress the abnormal proliferation and metastasis of
tumor cells. All these researches provided not only a good
basis for the functional research but also a promising
treatment of salivary gland tumors by using RNAi [17].
SACC-M derived from SACC-2 is a salivary adenoid cystic
carcinoma cell line with high tendency of lung metastasis,
and mainly has the differentiated and biological feature of
the neoplastic myoepithelial cell. In this study, we con-
structed the short hairpin RNA (shRNA) expression vector
targeting the coding regions of human XTLY-I gene to
observe the relationship between SACC and proteogly-
cans. After the shRNA plasmid was introduced into SACC-
M cells, the efficiency of XTLY-I gene suppression and pro-BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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teoglycans reductoin were evaluated. Then the impact of
down-regulated proteoglycans on cell migration and inva-
sion was observed, the relationship between proteogly-
cans and the potential lung metastasis of SACC-M was
analyzed as well.
The data of this research showed that the specific down-
regulation of human XTLY-I by RNAi led to the decrease
of proteoglycans in SACC-M cells; meanwhile the migra-
tion and invasion of SACC-M cells were inhibited signifi-
cantly. Our research revealed that proteoglycans was a key
factor in the process of invasion and metastasis of SACC.
Thus, the suppression of proteoglycans may be an option
for the treatment of SACC. The result of this research will
also provide a new idea for RNAi usage in salivary gland
tumor therapy.
Methods
Reagents and Cell lines
The human salivary adenoid cystic carcinoma cell line
with high tendency of lung metastasis (SACC-M) was
obtained from the Department of Oral and Maxillofacial
Surgery, College of Stomatology, Shanghai Ninth People's
Hospital Affiliated to Shanghai Jiaotong University. The
cells were grown in Dulbecco's modified Eagle's medium
(DMEM) (Hylone, Carlsbad, USA) containing 1500 mg/L
glucose. All DMEM supplemented with 10% fetal bovine
serum (Gibco, Gaithersburg, MD), penicillin and strepto-
mycin at 37°C in a humidified atmosphere of 95% air
and 5% carbon dioxide (NU-4750E, USA). The NIH3T3
cell line was kindly provided by Dr. Chao Wang (Hebei
Medical University, P. R. China) and cultured in DMEM
(Hylone, Carlsbad, USA) containing 4500 mg/L glucose
and 1.5 mM l-glutamine supplemented with 10% fetal
bovine serum.
Reagents were prepared and obtained from the following
companies, Lipofectamine™2000 and TRIzol (Invitrogen,
Karlsruhe, Germany); Blyscan Sulfated GAGs Assay (Bio-
color, London, UK); SYBR Real-Time PCR premix Ex Taq
Kit (Takara, Japan); RT-PCR Kit was from SBS Genetech
co., Ltd. (Beijing, China). Rabbit anti-GAPDH polyclonal
antibody, rabbit primary antibodies for XTLY-I and Pgen-
esil-1 vector (Genesil Biotechnology Co., Ltd., China)
[18]. The enzymes of T4 DNA Ligase, BamHI, HindIII, SalI,
and PstI were from NEB Company (London, UK),
Matrigel (Sigma, USA), Millicell chamber (with 8 μm
diameter microspore, Millipore, USA), goat anti-rabbit
horseradish peroxidase-conjugated secondary antibody
(Santa Cruz Biotechnology) chemiluminescence reaction
(Pierce, Rockford, IL). All BALB/C-nu mice used in this
experiment received humane care. The nude mice were
purchased from Laboratory Animal Center of Beijing
Xiehe Medical University, P. R. China. Twenty 4-week-old
female mice were chosen in this study. The animals were
fed with certified standard diet and sterilized water in the
condition of SPF with 25°C temperature and 30%~60%
of humidity.
The Design of shRNA and the Construction of Expression 
Vector
The human gene XTLY-I (Genbank accession number:
NM_012688) was selected from GenBank. According to
shRNA design principle [19], the shRNA sequence
designed targeting nucleotide 2621-2642 of XTLY-I
mRNA sequence is: AACAGGCAGCCCATCAAACCT. It
was ensured that the selected shRNA sequence was differ-
ent from other genes of human genome. EST database was
searched by using BLAST http://www.ncbi.nlm.nih.gov/
BLAST and no other isogenous genes were found. The neg-
ative control named shRNA-HK was designed and its
sequence (GACTTCATAAGGCGCATGC) was not isoge-
nous with any human gene. In order to overcome the dis-
advantages of short time action and lack of regenerating
ability of small interfering RNA (siRNA)[20], the encod-
ing shRNA plasmid expression vector was used with the
U6 promoter and neor gene in this study. The hairpin loop
of shRNA was TTCAAGAGA and the transcription termi-
nator was four continuous T.
The shRNAs were subcloned into the Pgensil-1 with
human U6 promoter (Fig. 1A), between the SalI and XbaI
restriction sites. All of the constructs used in this study
were verified by DNA sequencing. Once the requirement
had been met, a large-scale preparation of plasmid DNA
was extracted; the DNA plasmids were named shRNA-WJ4
(the RNAi plasmid), shRNA-HK (the nagetive control
plasmid), respectively. The structure of the shRNA vector
is:BamHI + Sense + Loop + Antisense + ending signal + SalI
+ HindIII [21].
Cell Transfection and Generation of Stable Cell Line
Twenty-four hours before transfection, SACC-M cells were
plated in a 6-well plate with 1 × 105 cells per well until the
cells reached the 70%~80% confluence at next day. They
were washed twice by DMEM (containing 1500 mg/L glu-
cose), then 2 ml DMEM free of fetal bovine serum and
antibiotics was added into each well. The cells were trans-
fected according to the manufacturer's protocol of cati-
onic lipid complexes Lipofectamine™2000. SACC-M cells
transfected with DMEM medium lacking DNA plasmid
served as the blank control. SACC-M cells transfected with
shRNA-HK served as the negative control. The 4.0 μg DNA
plasmid and 10 μl Lipofectamine™ 2000 was diluted by
250 μl DMEM, respectively. Then being mixed and stayed
at room temperature for 15~20 min, the compound was
added to each well and thoroughly mixed with medium.
Fresh growth medium with fetal bovine serum was
replaced after 6 hours of transfection. Efficiency was eval-
uated after 48 hours of transfection by observing the greenBMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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Construction of shRNA vector targeting human XTLY-I gene Figure 1
Construction of shRNA vector targeting human XTLY-I gene. A: The construct of Pgenesil-1 vector: This RNAi vec-
tor was a self-inactivating retroviral expression vector designed to express a small interfering dsRNA (siRNA) using the human 
U6 promoter. Neomycin-resistant selecting marker was used to select for stable clones. GFP was used to determine the suc-
cessful transfection. B: shRNA-WJ4: AGCTTGTCGACAAAAAACAGGCAGCCCATCAAACCTCGTCTTGAAA G GTTT-
GATGGGCTGCCTGCG.BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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fluorescent protein (GFP) expression under the fluores-
cence microscope (Olympus PM-10A, Japan).
After 48 hours of transfection the stable transfectant cells
were acquired by using G418 (500 μg/ml). Culture
medium was replaced at least twice per week. A stable cell
pool was selected after addition of G418 for about 3
weeks. Visible cell clones were picked up and expanded.
The stable transfectant cells expressing green fluorescence
were observed under microscope, however the cells with-
out shRNA plasmid did not show any green fluorescence.
Three groups included in this study were: group SACC-M:
the normal cultured SACC-M cells; group SACC-M-HK:
transfected with the negative control plasmid shRNA-HK;
group SACC-M-WJ4: transfected with shRNA-WJ4.
Real-Time Quantitative PCR for XTLY-I mRNA Expression
The genotypes of the stable G418 resistance cells SACC-M-
WJ4 and SACC-M-HK were detected by real-time quanti-
tative PCR. Total RNA was extracted from SACC-M-WJ4,
SACC-M-HK and SACC-M cells by using Trizol reagent as
described in the manufacture's instruction. The produc-
tion of cDNA was amplified by using gene-specific prim-
ers (shown in Table 1). Real-time quantitative PCR was
performed by GenAmp PCR system 2700 (AB Company,
USA) and SYBR Green I Real-Time PCR premix Ex Taq Kit
following the manufacture's protocols. The results were
analyzed by using the Light Cycle Real-time PCR System
(Switzerland Roche Company) to obtain Cycle threshold.
Finally, the computer analyzed the fluorescence signal
automatically. All quantitative data were normalized to an
endogenous control GAPDH. The relative quantitative
value of each targeting gene was analyzed by using a com-
parative copy number. The mRNA expression of target
gene in each cycle was obtained [22].
Western Blot Analysis for XTLY-I Protein Expression
The protein expression of XTLY-I in SACC-M-WJ4 cells
and SACC-M-HK cells was detected by Western blot, and
then compared with SACC-M cells. Cells were seeded in
100 cm2 flasks. Twenty-four hours after plating, confluent
cell layers were washed with ice-cold PBS and lysed for 30
min at 4°C with 1% NP-40, 0.1% Triton X-100, 30 mM
sodium phosphate (pH 7.4) containing 1 mM sodium
orthovanadate, 2.5 mM Tris-HCl (pH 7.5), 100 mM NaCl
and 10 μg/mL of leupeptin, aprotinin. Then, the homoge-
nate was centrifuged at 12,000 g for 20 min at 4°C. The
supernatant was collected and protein was quantified
with the Bio-Rad protein colorimetric assay. After addi-
tion of sample buffer to the cellular extract and boiling
samples at 95°C for 5 min, protein was separated on 8%
SDS-PAGE gel. Protein was transferred onto PVDF mem-
brane (Millipore Corporation, Bedford, MA) and the
membrane was blocked for 1 h at room temperature with
5% BSA (bovine serum albumin) in Tris-buffered saline
containing 0.05% Tween 20 (TBST). Next, blots were
washed and incubated overnight at 4°C in TBST contain-
ing 1% BSA with rabbit primary antibodies for XTLY-I (1:
1000) and rabbit anti-GAPDH (1: 2000). Membranes
were washed three times with TBST, incubated with goat
anti-rabbit horseradish peroxidase-conjugated secondary
antibody (1: 2500 dilution in TBST containing 1% BSA)
for 120 min at room temperature and then washed three
times with TBST. After chemiluminescence reaction,
bands were detected by exposing the blots to X-ray films
for the appropriate time period. For quantitative analysis,
bands were detected and evaluated densitometrically with
Foretix ID software, normalized for GAPDH density.
Quantitation of Proteoglylcans (Total GAGs)
The cell culture supernatant of the three groups was col-
lected and the content of total GAGs, which is the major
component of proteoglycans, was measured. The total
GAGs were quantitated using the Blyscan™ Sulphated Gly-
cosaminoglycan Assay Kit according to the manufacturer's
instructions. The assay was based on a colorimetric reac-
tion between the negatively charged GAGs and the posi-
tively charged dye dimethylmethylene blue (DMB)
[23,24]. Concentration was determined from the standard
curves of chondroitin sulfate A. Meanwhile the corre-
sponding cells were digested by trypsin and counted care-
fully. The content of proteoglycans secreted by 1 × 106
cells was detected at different time of 24, 48, 72, 96 and
120 hours, respectively.
Cell Adhesion to Matrigel
The 96-well plates were coated with Matrigel according to
the producer's guideline. Cells including SACC-M-WJ4
cells, SACC-M cells and SACC-M-HK cells were seeded
onto the Matrigel-coated wells (1 × 104 cells per well),
respectively. After being incubated at 37°C with complete
medium (pH 7.2) for 1 hour, the wells were washed and
Table 1: Real-time PCR primers
Gene Sequence Product Sizes
XTLY-I 5'-GCCTGGAAAGTGATAGCACTAAA-3'
5'-GGAGCAATGGAAGGGTAAAGA-3'
106 bp
GAPDH 5'-CATGAGAAGTATGACAACAGCCT-3'
5'-AGTCCTTCCACGATACCAAAGT-3'
113 bpBMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
Page 6 of 15
(page number not for citation purposes)
the cells adhere to Matrigel firmly were lysed in 20 μl MTT
for 4 hours at 37°C. Then 150 μl DMSO was added into
each well and spectrometric absorbance was measured at
the wavelength of 490 nm, the cell adhesion ratio was
determined as follow: (value of experimental group/value
of blank control - 1) × 100%. Each experiment was per-
formed at least three times independently.
Matrigel Invasion Assay
Cell invasiveness was determined in vitro to evaluate the
ability of SACC-M cell to transmigrate a layer of recon-
structed extracellular matrix (Matrigel). Three group cells
of SACC-M-WJ4, SACC-M and SACC-M-HK (3 × 105 cells
in 1 ml of DMEM containing 0.1% BSA) were assayed in
triplicate for Matrigel invasion at 37°C in a humid incu-
bator (95% air, 5% CO2) for 24 hours by using Millicell
chambers (Millipore, MD), respectively. The polycar-
bonate filters (13 mm in diameter, 8-μm pore size; Costar
Scientific, Cambridge, MA) were coated with Matrigel as
described in the introduction. DMEM medium condi-
tioned by NIH3T3 fibroblasts was used as a chemoattract-
ant and added into the lower compartment of the Millicell
chamber. DMEM containing 1% serum and 0.1% BSA was
added into the upper compartment of the Millicell cham-
ber instead of the chemoattractant. After 24 hours incuba-
tion, the filters were removed and fixed with methanol for
15 min; the cells on the upper side of the membrane were
removed. Invasive cells, which were able to breach 8 μm
pores and grew on the lower side, were stained with hema-
toxylin and eosin, the cells migrating to the lower side of
the PVPF membrane were counted under the inverted
microscope (Olympus PM-10A, Japan) in 5 fields selected
randomly (100× magnification). Each experiment was
repeated three times.
Wound Healing Assay
Wound healing assay was carried out to determine the cell
protrusion and migration ability of tumor cells. SACC-M
cells and their derivative cell lines were seeded into 6-well
dishes and grew until 80% - 90% confluence. Sterilized
one-milliliter pipette tip was used to generate wounding
across the cell monolayer, and the debris was washed with
PBS. Migration of cells into the wound was then observed
at different time. Cells migrated into the wounded area or
protruded from the border of the wound were visualized
and photographed under the inverted microscope at dif-
ferent time. A total of nine areas were selected randomly
in each well by a 100× magnification and cells in three
wells of each group were quantified in each experiment.
Experiments were carried out in triplicate at least three
times.
Experimental Lung Metastasis
Twenty 4-week-old female BALB/C nude mice were rand-
omized into 4 groups of 5 mice each. The tail veins of
nude mice were injected with 0.2 ml of cell suspension
containing 2 × 106 cells of SACC-M-WJ4, SACC-M-HK and
SACC-M, respectively, and normal saline (N.S) instead of
tumor cells was injected into the tail veins acted as normal
control. The nude mice were sacrificed at the 6th week after
injection. The fresh lung samples were harvested and
weighed; the metastasis rates and the number of metasta-
sis nodules on the lung surface were detected. The lung
samples were used for histopathology analysis. Formalin-
fixed/paraffin-embedded specimens were prepared by
ordinary procedures, 4 μm thick sections were stained
with hematoxylin and eosin, and then examined under
the microscope (Olympus AX-80, Japan) to evaluate the
morphological changes of metastasis tumors. The size and
metastasis grading were detected.
Statistical Analysis
Software SPSS 10.0 was used for all statistical evaluation.
All data were expressed as mean ± standard error. Data
were analyzed for statistical significance by using one-way
ANOVA. P < 0.05 was considered statistically significant.
Results
Construction of shRNA vector targeting human XTLY-I 
gene and the isolation of clones stably expressing shRNA 
targeting XTLY-I
The plasmid Pgenesil-1 has PstI digestion sites. After the
insertion of segments of target gene template DNA, the
PstI digestion sites were replaced. In the inserted target
gene template DNA, a SalI digestion site was designed
between BamHI and HindIII of Pgenesil-1. Once it was
correctly inserted, SalI produced a 400 bp DNA segment
and it was correctly identified. The bacteria solution of
transformation was tested by Shanghai Yingjun Company
with the results in agreement with the design. The eukary-
otic expression vector of shRNA targeting human XTLY-I
gene was constructed and named shRNA-WJ4. The nega-
tive control plasmid was named shRNA-HK. Successful
constructions were identified by digestion and sequencing
analysis (Fig. 1B). The plasmid shRNA-WJ4 and negative
control shRNA-HK was transfected into SACC-M cells,
respectively. SACC-M cells transfected with the plasmids
expressed green fluorescent successfully. Transfection effi-
ciency (≈ 70%) was evaluated after 48 hours of transfec-
tion (Fig. 2B). After G418 selection for about 3 weeks, the
stable sub-clone cells named SACC-M-WJ4 (expressed
shRNA-WJ4) were isolated and pooled together for fur-
ther analysis (Fig. 2C). The negative control SACC-M-HK
cell expressed shRNA-HK was isolated by the same
method and no obvious change in cell morphology was
observed in comparison with the parental cells (Fig. 2A).
These clones were used for the subsequent experiments
ShRNA expressing vector inhibited XTLY-I gene and 
proteoglycans secreted by SACC-M cells decreased
In order to detect the silence efficiency of shRNA expres-
sion vector targeting XTLY-I gene, real-time PCR was per-BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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formed to detect the mRNA expression. The protein
expression of XTLY-I was detected by Western blot analy-
sis as well in the stably transfected cells and their parental
cells. The results showed that the XTLY-I mRNA of SACC-
M-WJ4 cells was 0.381 consistent with the protein expres-
sion levels (0.103) (Fig. 3A-F & Table 2). The results of
Western blot demonstrated clearly that SACC-M-WJ4 cells
showed a dramatic decrease in the expression of XTLY-I
protein (Fig. 4A-B & Table 2). The RNAi plasmid shRNA-
WJ4 showed powerful RNAi effect compared with the two
controls. The mRNA expression of SACC-M-WJ4
decreased by 86.81%, and the protein expression was
decreased by 80.10%, respectively. The data demonstrated
that DNA-based shRNA vector constructed in this study
was effective in XTLY-I gene silence in SACC-M-WJ4 cells.
Then the level of proteoglycans (the total GAGs) secreted
by the three group cells was tested by biocolor method.
Overall, the GAGs secreted by the three kinds of cells from
24 hours to 96 hours were much more than that of 96
hours to 120 hours. The detail data showed that the effec-
tive silence of human XTLY-I gene reduced the secretion of
GAGs dramatically in SACC-M-WJ4 cells as shown in
Table 3 and Fig. 5. Compared with the parental SACC-M
cells and SACC-M-HK cells, the total GAGs selected by
SACC-M-WJ4 cells decreased significantly during the
whole experimental period, there was significant differ-
ences between SACC-M-WJ4 cells and SACC-M cells (P <
0.05); There was no significant difference between SACC-
M-HK cells and SACC-M cells at the secretion of GAGs (P
< 0.05). The total GAGs inhibitory rate of SACC-M-WJ4
cells was 58.17% (24 h), 66.06% (48 h), 57.91% (72 h),
59.36% (96 h), and 55.65% (120 h) respectively, as
shown in Table 4. These data indicated that the silence of
human XTLY-I gene was responsible for the suppression
SACC-M cells and the cell clone (A-C) Figure 2
SACC-M cells and the cell clone (A-C). (A): The SACC-M cells. (The inverted microscope, × 100); (B): Forty-eight hours 
after transfection with shRNA-WJ4 expressed green fluorescent protein (The inverted fluorescent microscope, × 100); (C): A 
cell clone of SACC-M-WJ4 selected with G418 (The inverted fluorescent microscope, × 100).BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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of proteoglycans secretion and biosynthesis in SACC-M-
WJ4 cells.
Down-regulated proteoglycans inhibited the ability of 
adhesion and metastasis of SACC-M cells
It was generally believed that extracellular matrix mole-
cules were involved in tumor metastasis and proteogly-
cans contained lots of cell adhesion factors act as
important regulators in this metastasis. Cell adhesion to
extracellular matrix is a preliminary step during the inva-
sion and metastasis of tumor cell. Therefore, the effect of
down-regulated proteoglycans on tumor invasion was
investigated by observing the change of cell adhesion. The
detection of cell adhesion of SACC-M, SACC-M-HK and
SACC-M-WJ4 cells was performed by the adhesion assay.
The adhesion rate of group SACC-M -WJ4 was 13.43 ±
2.91%, much lower than that of group SACC-M (23.3 ±
3.96%) and group SACC-M- HK (22.43 ± 4.85%), P <
0.05. On adhesion assays, SACC-M-WJ4 cells showed a
42.36% decrease in binding to Matrigel compared with
that of the negative control. There was no significant dif-
ference between SACC-M-HK and SACC-M cells (shown
in Fig 6). The data demonstrated that reduction of prote-
oglycans could indeed decrease the ability of cells to
adhere to extracellular matrix molecules.
Suppression of proteoglycans decreased the ability of 
Matrigel transmembrane migration of SACC-M cells
Invasion of basement membranes is thought to be a criti-
cal event in tumor metastasis. It is known that proteogly-
cans secreted from the tumor cells was not only
responsible for the formation of basement membranes,
but also mediate the invasion of tumor cells. This process
is best evaluated in vitro by the transmigration of a biolog-
ically active matrix such as Matrigel. Therefore, we meas-
ured the ability of these cells to transmigrate through the
Matrigel membrane. Significant differences in cell inva-
The results of Real-Time PCR (A-F) Figure 3
The results of Real-Time PCR (A-F). (A) The amplifica-
tion fragment of XTLY-I gene; (B) The XTLY-I mRNA 
expression in different groups: Group SACC-M-WJ4 com-
pared with that of group SACC-M and SACC-M-HK (P < 
0.05); (C) The fluorescent quantitative curve of positive 
standard samples of XTLY-I gene; (D) The fluorescent quan-
titative standard curve of XTLY-I gene; (E) The fluorescent 
quantitative curve of standard samples of GAPDH; (F) The 
fluorescent quantitative standard curve of GAPDH.
The protein expression of XTLY-I by Western blot analysis Figure 4
The protein expression of XTLY-I by Western blot 
analysis. (A): Detection of XTLY-I protein expression in dif-
ferent groups by Western blot analysis. Band of XTLY-I (120 
kDa.) was identified in different cells. Lane 1: SACC-M cells; 
lane 2: SACC-M-HK cells; lane 3: SACC-M-WJ4 cells. Fig. 4 
(B): The comparison of XTLY-I protein expression in differ-
ent groups. Value (XTLY/GAPDH) means the band inte-
grated opitical density (IOD) ratio of XTLY and GAPDH.
Table 2: The expression of mRNA and protein of XTLY-I gene 
(mean ± SD)
Value SACC-M SACC-M-HK SACC-M-WJ4
mRNA 2.609 ± 0.001 2.898 ± 0.025 0.381 ± 0.000
Protein 0.518 ± 0.036 0.446 ± 0.062 0.103 ± 0.030
Statistic result* A A B
*The same letters in the statistical results between the two groups 
showing no significant difference, while different letters showing 
significant differences.BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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sion were observed in this analysis. As shown in Fig. 7: A-
D, under the same condition of incubating, SACC-M-WJ4
cells display a significantly lower transmembrane migra-
tion activity (Fig. 7C). The transmembrane cell of group
SACC-M-WJ4 cells was 41.50 ± 8.35; much lower than
that of group SACC-M-HK (83.53 ± 10.21) (Fig. 7A) and
group SACC-M cells (90.50 ± 15.28) (Fig. 7B), P < 0.05;
the transmembrane cells of group SACC-M-WJ4 was
decreased by 54.14% compared with that of the negative
control. There was no significant difference between
SACC-M-HK and SACC-M cells. These data showed that
SACC-M-WJ4 cells with down-regulated proteoglycans
could inhibit the ability of their invasion through
Matrigel.
Suppression of proteoglycans secretion decreased cell 
mobility
The metastatic potential of tumors depends on the ability
of tumor cell to invade and migrate to distant sites. Active
cell motility is another important step of tumor cell inva-
sion. The mobility of cells was measured by using a well-
established wound healing assay in vitro. The results
showed that after 12 hours of scraping, the cells of group
SACC-M-WJ4 migrating into the wounding region was
115.92 ± 6.81, much less than that of group SACC-M-HK
(283.53 ± 9.72) and group SACC-M (289.50 ± 23.02),
such changes were statistically significant, P < 0.01. There
was no significant difference between SACC-M-HK and
SACC-M cells, as shown in Fig 8: A-I & Table 5.
Reduction of proteoglycans decreased the lung metastasis 
of SACC-M cells
We also tested the effects of down-regulated proteoglycans
on the potential metastasis of lung. SACC-M-WJ4, SACC-
M-HK and SACC-M cells were injected into the tail veins
of nude mice, respectively. The results showed that the
parental SACC-M cells resulted in the extensive lung
metastases (Fig. 9B), whereas the inhibition of proteogly-
cans synthesis in SACC-M-WJ4 cells reduced the lung
metastasis significantly (Fig. 9D). The lung metastasis of
group SACC-M-WJ4 was decreased to 40% (2/5), signifi-
cantly lower than that of group SACC-M-HK (100%) (Fig.
9C) and group SACC-M (100%), P < 0.05. The number of
metastasis nodes on the surface of lung was 49.4 ± 4.81 in
group SACC-M, 41.6 ± 8.09 in group SACC-M-HK and 4.8
± 3.89 in group SACC-M-WJ4, respectively, P < 0.01(Fig.
9E-F). The lung wet weight of group SACC-M-WJ4 (0.226
± 0.83 g) was significantly lower than that of group SACC-
M (0.897 ± 0.21 g) and group SACC-M-HK (0.786 ± 0.28
g), P < 0.01, shown in Table 6; there was no significant dif-
ference between group SACC-M-WJ4 and group N.S
(0.196 ± 0.03 g) (Fig. 9A &9D). This suggested an impor-
tant role of proteoglycans in the metastasis of SACC-M
cell (Table 6). Multinodular lesions on the surface and
inside of lung in group SACC-M-HK and group SACC-M
were observed, the sizes were from miliaria to pea, some
were larger to integrate several protuberances on the sur-
face. In group SACC-M-WJ4 only two mice had lung
metastasis with miliary nodules (Fig. 9E, &10).
The histopathological analysis of the lung samples
showed that no lung metastasis was found in group N.S,
and the normal structure of lung could be observed clearly
(Fig. 10A). The normal structures of lungs in group SACC-
The GAGs contents of the three groups in different time (μg/ 106 cells) Figure 5
The GAGs contents of the three groups in different 
time (μg/106 cells).
Table 3: The total GAGs content in each group (μg/106 cells) 
(mean ± SD, n = 3)
Times SACC-M SACC-M-HK SACC-M-WJ4
24 h 20.56 ± 1.03 19.85 ± 0.84 8.60 ± 0.94
48 h 48.71 ± 1.07 39.97 ± 1.34 16.53 ± 0.89
72 h 68.73 ± 3.23 65.19 ± 3.56 28.93 ± 1.34
96 h 91.0 ± 3.06 88.64 ± 3.52 41.56 ± 3.82
120 h 93.70 ± 3.08 91.21 ± 2.89 36.98 ± 2.47
Table 4: The inhibitory rate of total GAGs contents (%)
Group 24 h 48 h 72 h 96 h 120 h
SACC-M-HK 3.45 17.94 5.15 2.59 2.66
SACC-M-WJ4 58.17 66.06 57.91 59.36 55.65
The comparsion of cell adhesion rate of three groups Figure 6
The comparsion of cell adhesion rate of three groups.BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
Page 10 of 15
(page number not for citation purposes)
M (Fig. 10B) and group SACC-M-HK (Fig. 10C) were
almost destroyed. The lungs were full of metastasis nod-
ules with different sizes. The tumor cells were round or
polyhedral with eosinophilic cytoplasm and round
nucleus, arranged in dense clumps of solid, many mitoses
could be observed. Pulmonary vascular cavities were in
condition of hyperaemia. Only a few metastasis nodules
were found in the two lung samples of group SACC-M-
WJ4 and the normal structure of them was still remained
(Fig. 10D). The size of the metastasis nodule in group
SACC-M-WJ4 was much smaller than that of group SACC-
M and group SACC-M-HK, wrapped by an incomplete
capsule. Some of them were only cell lumps. The tumor
cells arranged loose with less mitosis. These data showed
that reduction of proteoglycans decreased the lung metas-
tasis of SACC-M cells.
Discussion
As a type II transmembrane proteins localized in Golgi
apparatus, human XTLY-I is a member of glycosyltrans-
ferase family 14, whose systematic name is UDP-α-D-
xylose: proteoglycan core protein β-D-xylosyltransferase.
It has determined that XTLY-I catalyzes the initial step in
Suppression of proteoglycans hampered transmembrane  migration ability of SACC-M-WJ4 cells Figure 7
Suppression of proteoglycans hampered transmem-
brane migration ability of SACC-M-WJ4 cells. (A): 
SACC-M cells migrating to the lower side of membrane 
coated by Matrigel; (B): SACC-M-HK cells migrating to the 
lower side of membrane coated by Matrigel; (C): SACC-M-
WJ4 cells migrating to the lower side of membrane coated by 
Matrigel; (D): Compared with group SACC-M and group 
SACC-M-HK, the invading ability of SACC-M-WJ4 reduced 
by over 50%.
Table 5: The results of wound healing assay (Mean ± SD)
Group Cell numbers
SACC-M 289.50 ± 23.02 *
SACC-M-HK 283.53 ± 9.72**
SACC-M-WJ4 115.92 ± 6.81
*compared with group SACC-M-WJ4: P < 0.01;
**compared with group SACC-M-WJ4: P < 0.01;
*compared with **: P > 0.05.
Suppression of proteoglycans decreased the migration of  SACC-M-WJ4 cells Figure 8
Suppression of proteoglycans decreased the migra-
tion of SACC-M-WJ4 cells. (A): Wound healing assay of 
group SACC-M (0 h); (B): Wound healing assay of group 
SACC-M (12 h); (C): Wound healing assay of group SACC-
M-HK (0 h); (D): Wound healing assay of group SACC-M-HK 
(12 h); (E): Wound healing assay of group SACC-M-WJ4 (0 
h); (F): Wound healing assay of group SACC-M-WJ4 (12 h); 
(G): Wound healing assay of group SACC-M (48 h); (H): 
Wound healing assay of group SACC-M-HK (48 h) (I): 
Wound healing assay of group SACC-M-WJ4 (48 h).BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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which GAGs chains were attached to the core protein. This
step is rate-limited and is thought to be the most impor-
tant regulator in proteoglycans biosynthesis [6,25].
Recent advances in mammalian have showed that XTLY-I
activity is a biochemical marker for the assessment of pro-
teoglycan-associated diseases [26], such as systemic scle-
rosis, diabetic nephropathy, osteoarthritis,
pseudoxanthoma elasticum (PXE), etc. The studies
pointed out the important role of XTLY-I as a disease
modifier in pathologies with an altered proteoglycans
metabolism. In vivo in salivary gland, the acinus and duct
cells do not produce and secrete proteoglycans, so they do
not express proteoglycans and XTLY-I. Recently years, the
research of Jie W. et al. had demonstrated that the normal
myoepithelial cells do not synthesize and secrete prote-
oglycans, but when they transform to tumor cells, the neo-
plastic myoepithelial cells in salivary gland tumors, they
have the ability to synthesize and secrete proteoglycans
abnormally [14,27]. The similar results had been also
demonstrated by other researches [28,29]. As the crucial
impact of XTLY-I on proteoglycans synthesis and in order
to determine the role of proteoglycans in the metastasis of
human SACC, XTLY-I gene was blocked by shRNA expres-
sion vector to suppress the biosynthesis of proteoglycans
in SACC-M cells. This study showed that the biosynthesis
and secretion of proteoglycans could be supressed in
tumor cells by the silence of XTLY-I.
RNAi in mammalian is to inhibit the function of specific
gene by introducing siRNA or siRNA expression vector
with high silent efficiency into subjects (such as cells, tis-
sues, etc.). For effective gene silence mediated by RNAi,
vector plasmids have been constructed to express siRNA as
inverted repeats showing similar potency to initial RNAi.
These siRNA-like molecules are commonly designated as
shRNA. For generating shRNAs, these vectors have been
designed to be able to obtain the stable expression of
shRNA by using strong RNA polymerase-II-dependent
promoters like CMV, or RNA polymerase-III promoters
like U6 or H1. As RNA polymerase-III expression systems
can offer a great potency for maintaining stable expression
of short RNA molecules in vitro as well as in vivo [20], the
U6-driven expression vector Pgensil-1 was applied in this
study. The size of the loop structure of shRNA has a con-
siderable influence on the gene suppression activity. A
mounting research reported that a 9-nucleotide loop
showed more effects than a 7-nucleotide or 5-nucleotide
loop [30-32]. Therefore, the shRNA was designed with a
9-nucleotide loop in this study.
The DNA-based vector plasmid shRNA-WJ4 in this study
showed powerful RNAi efficiency, whereas the negative
control shRNA-HK did not show any significant RNAi
effect on SACC-M cells. When mRNA and protein levels of
XTLY-I were measured simultaneously, there was a good
match between RNA transcript loss and protein loss, indi-
cating that the primary mechanism of gene knockdown
was RNA transcript-mediated knockdown, which required
a high degree of sequence homology between the siRNA
and target sequences.
After the silence of XTLY-I gene, the cells could not synthe-
size the following GAGs chain, which attached to the core
protein of proteoglycans, then the biosynthesis of prote-
oglycans could not be achieved [33]. As proteoglycans
were secreted mainly into the extracellular matrix, the
total GAGs in cell culture medium were the proteoglycans
Table 6: Lung weight with metastatic nodes (Mean ± SD)
Group Wet weight (g)
SACC-M 0.897 ± 0.21*
SACC-M-HK 0.786 ± 0.28**
SACC-M-WJ4 0.226 ± 0.83
N.S 0.196 ± 0.03
*compared with group SACC-M-WJ4 and group NS, respectively: P < 
0.01; **compared with group SACC-M-WJ4 and group NS, 
respectively: P < 0.01; *compared with **: P > 0.05;
group SACC-M-WJ4 compared with group N.S: P > 0.05.
Lung metastasis samples of different groups (A-E) Figure 9
Lung metastasis samples of different groups (A-E). 9 
(A) The normal lung of group N.S without metastatic tumor; 
(B) The lungs of group SACC-M with many metastatic 
tumors; (C) The lungs of group SACC-M-HK full of meta-
static tumors; (D) The lungs of group SACC-M-WJ4 with few 
metastatic tumors; (E) The lung samples of the different 
group fixed with Formalin. (F) The number of metastasis 
node on lung surface of different group.BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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secreted by SACC-M cells indeed. The data of this research
showed that the silence of human XTLY-I gene resulted in
the inhibition of proteoglycans secretion. The total GAGs
secreted by SACC-M-WJ4 cells reduced dramatically dur-
ing the experimental times. Meanwhile, we also trans-
fected SACC-83 cells with shRNA-WJ4 plasmid, the
reduction of total GAGs was observed clearly (data not
shown). The data demonstrated that the expression of
XTLY-I gene was related to proteoglycans level closely.
Invasion and metastasis are the major biological charac-
teristics of SACC, and also an important indicator of
malignancy. Extracellular matrix plays an important and
necessary role in the process of tumor invasion and metas-
tasis. Extracellular matrix mainly consists of two com-
pounds: basement membrane and connective tissue.
Since most proteoglycans such as heparan sulphate prote-
oglycan (HSPG), keratan sulphate proteoglycan (KSPG),
chondroitin sulfate proteoglycans (CSPG) etc. express on
the surface of cytoplasmic membrane and deposit in the
extracellular space, they are not only the major compo-
nent of mesenchyme but also the main component of
basement membrane. The secretion level and the type of
proteoglycans impact the function of extracellular matrix
in tumor to a great degree [1].
SACC is the most characteristic malignancy of oral and
maxillofacial regions. Previous studies showed that neo-
plastic myoepithelial cells in SACC secreted different pro-
teoglycans including HSPG, KSPG, CSPG and hyaluronan
(HA), etc. Proteoglycans, which showed complex effect on
tumor invasion and metastasis, were closely related to the
invasion and metastasis of SACC [28,34,35]. SACC histo-
logically characterized by a cribriform appearance
resulted from multi-pseudocystic spaces. Evidences indi-
cated that extracellular matrix molecules and their recep-
Histological observation of the lung in four groups (A-D) Figure 10
Histological observation of the lung in four groups (A-D). (A): The normal lung of group NS (HE × 100); (B) Many met-
astatic nodes in the lung of group SACC-M (HE × 100); (C) Many metastatic nodes in the lung of group SACC-M-HK (HE × 
100); (D) Only a few smaller metastatic nodes in the lung of group SACC-M-WJ4 (HE × 100).BMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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tors played important role in the morphogenesis of SACC.
Clinical data showed that SACC with cribriform pattern
had a better prognosis than those with a solid pattern.
There were more patients with solid pattern occurring
early recurrence and distant metastases. Although SACC
patients with a cribriform pattern rich in proteoglycans
had less distant metastasis, they underwent local recur-
rence more easily. However, solid SACC lack of proteogly-
cans had the worst survival rate in all kinds of SACC
[29,35-38]. It seemed to imply that abundant proteogly-
cans in extracellular matrix could suppress the invasion of
SACC. SACC-M cells are highly invasive and tumorigenic
isolated from a SACC cell line SACC-2 that derived from
human minor salivary gland in palate. Some scholars had
compared the proteoglycans expression in SACC-M cell
and its parental cell SACC-2; the expression of proteogly-
cans was significant higher in SACC-M cells with a high
potential metastasis. The speed of proteoglycans biosyn-
thesis and deposition in the extracellular matrix was sig-
nificantly increased than that of SACC-2 cells [39].
Kimuras et al. [29] had found in their study, the ability of
cell adhesion and growth was enhanced significantly
when the cells were cultured in the media rich of prote-
oglycans. These researches supported that the existence of
sufficient proteoglycans promoted the metastasis of
tumor.
The metastasis of tumor is a continuous process involved
in a variety of factors with homologous target. The basic
process of metastasis includes that tumor cells separate
away from the surrounding cells and migrate to the extra-
cellular matrix, then adhere to the basement membrane
and degrade them; simultaneously the cells infiltrate the
vascular and get to the target organ by degrading the wall
proteins. With the rapid proliferation of tumor cells and
the formation of new blood vessels, a metastasis neo-
plasm could successfully migrate to the distant organs. As
our knowledge, separation from the original tumor, cell
adhesion and degradation of the basement membrane
were the initial steps of tumor cell metastasis. Cell adhe-
sion to the basement membrane and destroying of base-
ment membrane were the key to tumor metastasis
procession. In tumors with high potential invasion and
metastasis, the cell adhesion of homogeneity usually
declined, whereas the cell adhesion of heterogeneity
increased [40,41]. In this study, the reduction of prote-
oglycans could inhibit the adhesion, invasion and metas-
tasis ability of SACC-M-WJ4 cells, the lung metastasis rate
was decreased to 40%, much lower than that of SACC-M
cells (100%). In our transient transfection of SACC-83
cells with shRNA-WJ4, the proliferation of tumor cell was
inhibited and the cell metastasis ability in vitro was sup-
pressed significantly compared with that of the control
(data not shown). The results suggested that proteogly-
cans perhaps provide an important support in the metas-
tasis of SACC cells.
Although the amount of different proteoglycans secreted
by the cells was not tested in this research, the results in
previous reports had shown that the main proteoglycans
secreted by SACC-M cells were HSPG, few CSPG, biglycan,
lumican, dermatan sulfate proteoglycans (DSPG), and
some core protein as well [28,39,42]. The proteoglycans
reduction was possible the suppression of HSPG to a great
degree, which was related closely to the ability of cell
migration and invasion. So, SACC-M-WJ4 cells showed
obviously lower lung metastasis than that of SACC-M cells
in this study.
It has been proved that there were many cell adhesion fac-
tors such as growth factors, cytokines and their receptor
that located in the GAGs chains. Proteoglycans had a reg-
ulatory role of cell adhesion and cell activity [43,44]. It is
known that the signal transfer of proteoglycans may medi-
ate the tumor metastasis, whereas HSPG is nearly the most
powerful proteoglycans, which carries out this function. It
has been known that HSPG synthesized inside the cells
stay on the cell membrane for a very short time, and then
deposit in the out space of cells. During this process over
dozens of HSPG play different functions to regulate the
cell metastasis [44-47].
It had been found that over-expression of HSPG pro-
moted the growth of SACC. Over-expression of HSPG is
often a prerequisite for the invasion and metastasis of
tumor cells. HSPG is not only acted as an important com-
ponent of basement membrane material, but also
involved in the degradation of basement membrane
[48,49]. As the most important transmembrane prote-
oglycans, HSPG plays a decisive role in regulating cell
adhesion and transmembrane signal transfer.
Meanwhile, many studies have confirmed that proteogly-
cans could combine with lots of cell factors such as HGF,
bFGF, VEGF, etc. to participate in the formation of
induced angiogenesis, which is the necessary process to
trigger tumor invasion and migration [50,51]. In the
research of myoepithelial salivary tumors, it had been
found that the proportion of HSPG/CSPG in the tumor
cells was closely related to the tumor metastasis. The up-
regulation of HSPG/CSPG proportion enhanced the abil-
ity of tumor metastasis, whereas the decline of CSPG/
DSPG inhibited tumor metastasis [52,53].
Some scholars had proposed that the proteoglycans
secreted by SACC cells provided sufficient nutrition for
the proliferation of the tumor cells [54]. Simultaneously
the signal receptors and cell adhesion factors holding by
proteoglycans could mediate the metastasis of tumor cells
and promote the invasion of SACC to distant organs.
Some researches also suggested that proteoglycans
secreted by SACC cells support the perineural invasion
during which energy was poorly supplied by tumor cellBMC Cancer 2009, 9:456 http://www.biomedcentral.com/1471-2407/9/456
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[55,56]. In our study, the data implied that the abnormal
biosynthesis of proteoglycans in SACC-M cells might be a
promoter for the invasion and metastasis of tumor cells.
The reduction of proteoglycans in this study resulted in
the inhibition of SACC-M cells adhesion, invasion and
migration. The probable reason might be as follows: 1)
Cells adhesion factors involved in cell invasion and
migration were lost or suppressed by the poor proteogly-
cans in tumor cells. 2) The decline of proteoglycans on the
surface of cytoplasmic membrane or in extracellular
matrix inhibited the signal transfer of cells and decreased
the cells metastasis. 3) The cell transfer factors could not
carry out their function actively without some kind of pro-
teoglycans and their corresponding receptors. It had been
known that the abnormal secretion of proteoglycans
could result in the dramatically proliferate of cells and this
is probably the mechanism of tumorigenesis [44,56]. We
also found in other part of our research that the down-reg-
ulated proteoglycans had suppressed the proliferation of
SACC-M cells dramatically (data not shown). With the
decline of proteoglycans, the growth of tumor cells might
be suppressed and this might result in the pronounced
inhibition of the metastatic activity of SACC cells.
Conclusions
To Sum up, in this research the knockdown of XYLT-I gene
in SACC-M cells by RNAi was effective. The significant
inhibition of proteoglycans biosynthesized by SACC-M
cells was detected. Our data clearly demonstrated that the
reduction of proteoglycans could suppress the biological
activities of SACC-M cells including cell adhesion, inva-
sion and lung metastasis. This research not only approved
a close relationship between proteoglycans and the metas-
tasis of SACC, but also provided a new idea for the clinical
treatment of SACC.
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